IL-17, a proinflammatory cytokine, plays context-dependent roles in cancer—its dysregulation promotes immunopathology, autoimmunity, and tumor progression (Amatya, Garg & Gaffen, 2017). The gene discussed is IL17A; the disease is cancer.